Literature DB >> 25544709

Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts.

Christine Staudigl1, Michaela Bartova, Mohamed Salama, Giorgi Dzagnidze, Zsuzsanna Bago-Horvath, Kamil Pohlodek, Christian F Singer, Muy-Kheng M Tea.   

Abstract

Approximately 6-15 % of breast cancer patients are diagnosed with primary ulcerated breast cancer (ULBC). ULBC is known to be associated with short recurrence free and poor overall survival. Therefore, the purpose of this study was to characterize ULBC and compare the histopathological findings with those of non-ulcerative breast cancer (NULBC). A total of 152 ULBCs were evaluated and compared to 304 consecutive non-ulcerated, age-matched breast malignancies. Patients mean age was 65 years (SD = 13.0 ULBC, SD = 14.0 NULBC). ULBC was associated with a higher rate of poorly differentiated tumors (p = < 0.001), as well as larger tumor sizes (p = < 0.001). As expected, the rate of axillary lymph node involvement was higher in ULBC patients (p = <0.001). In addition to that, ULBC was associated with a higher rate of triple negative breast cancer (p = 0.002), and higher Ki67 expression (p = < 0.001). ULBC showed more aggressive histopathological features in comparison to NULBC which may contribute to the generally known poorer prognosis of women with ULBC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544709     DOI: 10.1007/s13277-014-2977-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

Review 1.  Factors predicting delayed presentation of symptomatic breast cancer: a systematic review.

Authors:  A J Ramirez; A M Westcombe; C C Burgess; S Sutton; P Littlejohns; M A Richards
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

Review 2.  Ulcerative breast cancer: case report and review of management.

Authors:  M Fiegl; H Kaufmann; G G Steger
Journal:  Breast J       Date:  2001 Nov-Dec       Impact factor: 2.431

3.  Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer.

Authors:  Rupert Bartsch; Zsuzsanna Bago-Horvath; Anna Berghoff; Catharina DeVries; Ursula Pluschnig; Peter Dubsky; Margaretha Rudas; Robert M Mader; Andrea Rottenfusser; Florian Fitzal; Michael Gnant; Christoph C Zielinski; Guenther G Steger
Journal:  Eur J Cancer       Date:  2012-03-27       Impact factor: 9.162

Review 4.  Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

Authors:  Laura Biganzoli; Hans Wildiers; Catherine Oakman; Lorenza Marotti; Sibylle Loibl; Ian Kunkler; Malcolm Reed; Stefano Ciatto; Adri C Voogd; Etienne Brain; Bruno Cutuli; Catherine Terret; Margot Gosney; Matti Aapro; Riccardo Audisio
Journal:  Lancet Oncol       Date:  2012-03-30       Impact factor: 41.316

5.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

6.  Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

Authors:  Fiona M Blows; Kristy E Driver; Marjanka K Schmidt; Annegien Broeks; Flora E van Leeuwen; Jelle Wesseling; Maggie C Cheang; Karen Gelmon; Torsten O Nielsen; Carl Blomqvist; Päivi Heikkilä; Tuomas Heikkinen; Heli Nevanlinna; Lars A Akslen; Louis R Bégin; William D Foulkes; Fergus J Couch; Xianshu Wang; Vicky Cafourek; Janet E Olson; Laura Baglietto; Graham G Giles; Gianluca Severi; Catriona A McLean; Melissa C Southey; Emad Rakha; Andrew R Green; Ian O Ellis; Mark E Sherman; Jolanta Lissowska; William F Anderson; Angela Cox; Simon S Cross; Malcolm W R Reed; Elena Provenzano; Sarah-Jane Dawson; Alison M Dunning; Manjeet Humphreys; Douglas F Easton; Montserrat García-Closas; Carlos Caldas; Paul D Pharoah; David Huntsman
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

7.  Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

Authors:  Roberto Gennari; Giuseppe Curigliano; Nicole Rotmensz; Chris Robertson; Marco Colleoni; Stefano Zurrida; Franco Nolè; Filippo de Braud; Laura Orlando; Maria Cristina Leonardi; Viviana Galimberti; Mattia Intra; Paolo Veronesi; Giuseppe Renne; Saverio Cinieri; Riccardo A Audisio; Alberto Luini; Roberto Orecchia; Giuseppe Viale; Aron Goldhirsch
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

8.  Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Authors:  Sebastian F Schoppmann; Guenther Bayer; Klaus Aumayr; Susanne Taucher; Silvana Geleff; Margaretha Rudas; Ernst Kubista; Hubert Hausmaninger; Hellmut Samonigg; Michael Gnant; Raimund Jakesz; Reinhard Horvat
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 9.  Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.

Authors:  G Franceschini; D Terribile; S Magno; C Fabbri; P F D'Alba; F Chiesa; A Di Leone; R Masetti
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Sep-Oct       Impact factor: 3.507

10.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.

Authors:  S E Pinder; I O Ellis; M Galea; S O'Rouke; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1994-01       Impact factor: 5.087

View more
  1 in total

1.  Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas.

Authors:  Tadashi Iwai; Manabu Hoshi; Naoto Oebisu; Naoki Takada; Yoshitaka Ban; Hiroaki Nakamura
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.